Which statement about phosphate binders and bone-mineral disease in dialysis patients is correct?

Which statement about phosphate binders and bone-mineral disease in dialysis patients is correct?

• A. Management includes phosphate binders, vitamin D analogs, and calcium monitoring
• B. Phosphate binders are never used
• C. Vitamin D analogs are avoided
• D. Calcium monitoring is unnecessary

Answer: (A)

Managing bone-mineral disease in dialysis hinges on controlling phosphate, regulating parathyroid hormone, and balancing calcium. Phosphate binders are used to reduce intestinal phosphate absorption, which helps lower serum phosphate and mitigates secondary hyperparathyroidism. Vitamin D analogs are used to suppress PTH and promote healthier bone turnover by providing active vitamin D. Calcium monitoring is essential because calcium levels can rise with calcium-based binders or vitamin D therapy, and keeping calcium in a safe range helps prevent vascular calcification and other complications. Therefore, including phosphate binders, vitamin D analogs, and calcium monitoring reflects the standard, integrated approach to this condition. The other statements conflict with established practice: phosphate binders are not “never used,” vitamin D analogs are not avoided, and calcium monitoring is not unnecessary.

Managing bone-mineral disease in dialysis hinges on controlling phosphate, regulating parathyroid hormone, and balancing calcium. Phosphate binders are used to reduce intestinal phosphate absorption, which helps lower serum phosphate and mitigates secondary hyperparathyroidism. Vitamin D analogs are used to suppress PTH and promote healthier bone turnover by providing active vitamin D. Calcium monitoring is essential because calcium levels can rise with calcium-based binders or vitamin D therapy, and keeping calcium in a safe range helps prevent vascular calcification and other complications. Therefore, including phosphate binders, vitamin D analogs, and calcium monitoring reflects the standard, integrated approach to this condition. The other statements conflict with established practice: phosphate binders are not “never used,” vitamin D analogs are not avoided, and calcium monitoring is not unnecessary.